| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 57.76M | 55.06M | 59.14M | 55.59M | 54.51M |
| Gross Profit | 12.24M | 11.56M | 11.67M | 12.15M | 12.15M |
| EBITDA | 3.45M | -3.36M | 2.61M | 5.06M | 5.63M |
| Net Income | 3.63M | -3.84M | 2.05M | 2.75M | 3.05M |
Balance Sheet | |||||
| Total Assets | 131.24M | 125.97M | 140.52M | 143.89M | 137.77M |
| Cash, Cash Equivalents and Short-Term Investments | 52.21M | 54.87M | 55.19M | 61.68M | 64.40M |
| Total Debt | 2.78M | 922.00K | 932.00K | 1.00M | 908.00K |
| Total Liabilities | 29.56M | 16.23M | 20.79M | 22.23M | 17.01M |
| Stockholders Equity | 94.36M | 99.30M | 107.17M | 113.64M | 113.72M |
Cash Flow | |||||
| Free Cash Flow | -3.50M | -69.00K | -518.00K | 3.83M | -662.00K |
| Operating Cash Flow | 1.66M | 151.00K | 371.00K | 4.38M | 56.00K |
| Investing Cash Flow | -1.87M | 2.02M | -9.46M | -3.45M | -8.86M |
| Financing Cash Flow | -2.55M | -2.42M | 3.02M | -3.61M | -1.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | S$1.02B | 24.40 | 9.60% | 3.88% | 1.24% | -10.12% | |
65 Neutral | S$219.67M | 17.93 | 24.01% | 3.80% | 12.70% | 48.43% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | S$317.24M | 32.58 | 7.60% | 0.32% | 47.45% | 51.05% | |
54 Neutral | S$39.17M | 29.49 | 2.00% | 25.53% | 4.89% | ― | |
52 Neutral | S$535.94M | 39.08 | 2.87% | ― | 4.60% | ― |
Ellipsiz Ltd held its 30th Annual General Meeting on October 28, 2025, at Orchid Country Club in Singapore. The meeting was attended by the company’s directors, key management personnel, and representatives from various associated firms. The Chairman, Mr. David Ong Kim Huat, welcomed the attendees and confirmed the presence of a quorum, officially opening the meeting.
Ellipsiz Ltd held an Extraordinary General Meeting on October 28, 2025, at Orchid Country Club in Singapore, attended by the company’s directors, key executives, and stakeholders. The meeting was successfully convened with a quorum present, marking a significant step in the company’s governance and operational proceedings.
Ellipsiz Ltd, through its subsidiary ISE Foods Holdings Pte. Ltd., is progressing in the development of Singapore’s 4th Egg Farm (SG4EF). The company has identified a new plot of land and is working with the Singapore Food Agency and other government bodies to secure land ownership and regulatory approvals. The farm’s development includes selecting key equipment vendors and securing funding from various sources, including grants and loans. Construction is targeted to begin in the first half of 2026, pending necessary approvals.